Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 2 |
2021 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Risdiplam in Type 1 Spinal Muscular Atrophy.
N Engl J Med. 2021 Mar 11;384(10):915-923. doi: 10.1056/NEJMoa2009965. Epub 2021 Feb 24.
N Engl J Med. 2021.
PMID: 33626251
Clinical Trial.
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.
Darras BT, Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y, El-Khairi M, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Fontoura P, Servais L; FIREFISH Working Group.
Darras BT, et al.
N Engl J Med. 2021 Jul 29;385(5):427-435. doi: 10.1056/NEJMoa2102047.
N Engl J Med. 2021.
PMID: 34320287
Item in Clipboard
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, Klein A, Mercuri E, Vlodavets D, Wang Y, Dodman A, El-Khairi M, Gorni K, Jaber B, Kletzl H, Gaki E, Fontoura P, Darras BT; FIREFISH Study Group.
Masson R, et al.
Lancet Neurol. 2022 Dec;21(12):1110-1119. doi: 10.1016/S1474-4422(22)00339-8. Epub 2022 Oct 14.
Lancet Neurol. 2022.
PMID: 36244364
Clinical Trial.
Item in Clipboard
Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland.
Tscherter A, Rüsch CT, Baumann D, Enzmann C, Hasselmann O, Jacquier D, Jung HH, Kruijshaar ME, Kuehni CE, Neuwirth C, Stettner GM, Klein A; Swiss-Reg-NMD group.
Tscherter A, et al. Among authors: enzmann c.
Neuromuscul Disord. 2022 May;32(5):399-409. doi: 10.1016/j.nmd.2022.02.001. Epub 2022 Feb 9.
Neuromuscul Disord. 2022.
PMID: 35337708
Free article.
Item in Clipboard
Mental health challenges and digital platform opportunities in patients and families affected by pediatric neuromuscular diseases - experiences from Switzerland.
Gruebner O, van Haasteren A, Hug A, Elayan S, Sykora M, Albanese E, Stettner GM, Waldboth V, Messmer-Khosla S, Enzmann C, Baumann D, von Wyl V, Fadda M, Wolf M, von Rhein M.
Gruebner O, et al. Among authors: enzmann c.
Digit Health. 2023 Nov 16;9:20552076231213700. doi: 10.1177/20552076231213700. eCollection 2023 Jan-Dec.
Digit Health. 2023.
PMID: 38025108
Free PMC article.
Review.
Item in Clipboard
Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early infancy.
Hoeger PH, Enzmann CC.
Hoeger PH, et al. Among authors: enzmann cc.
Pediatr Dermatol. 2002 May-Jun;19(3):256-62. doi: 10.1046/j.1525-1470.2002.00082.x.
Pediatr Dermatol. 2002.
PMID: 12047648
Item in Clipboard
Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin.
Hoeger PH, Schreiner V, Klaassen IA, Enzmann CC, Friedrichs K, Bleck O.
Hoeger PH, et al. Among authors: enzmann cc.
Br J Dermatol. 2002 Feb;146(2):194-201. doi: 10.1046/j.1365-2133.2002.04584.x.
Br J Dermatol. 2002.
PMID: 11903227
Item in Clipboard
Cite
Cite